The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
| Title: | The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials |
|---|---|
| Authors: | Ntanasis-Stathopoulos, IoannisAff1; Filippatos, CharalamposAff1; Malandrakis, PanagiotisAff1; Koutoulidis, VassilisAff2; Trapali, MariaAff3; Kastritis, EfstathiosAff1; Terpos, EvangelosAff1; Dimopoulos, Meletios-AthanasiosAff1, Aff4; Gavriatopoulou, MariaAff1, IDs41375025026775_cor1 |
| Source: | Leukemia. 39(9):2226-2236 |
| Database: | Springer Nature Journals |